(Q33342924)

26 July 2017

1 reference

title

Heparin-induced thrombocytopenia: pathophysiology and management (English)

1 reference

heparin-induced thrombocytopenia

26 July 2017

1 reference

1 reference

1 reference

Leila Mureebe

1

1 reference

26 July 2017

Donald Silver

series ordinal

2

1 reference

26 July 2017

publication date

1 May 2002

1 reference

Vascular and Endovascular Surgery

26 July 2017

published in

1 reference

26 July 2017

volume

36

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

163-170

1 reference

Arterial Embolism Occurring During Systemic Heparin Therapy

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Drug-induced thrombocytopenia: a systematic review of published case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Do patients with the heparin-induced thrombocytopenia syndrome have heparin-specific antibodies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

The role of heparin-associated antiplatelet antibodies in the outcome of arterial reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Heparin induced thrombocytopenia: eight cases with thrombotic-hemorrhagic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Fundamental concepts in the pathobiology of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Anti-PF4-heparin immunoglobulin G is the major class of heparin-induced thrombocytopenia antibody: findings of an enzyme-linked immunofiltration assay using membrane-bound hPF4-heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Immune endothelial-cell injury in heparin-associated thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Laboratory testing for heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Heparin-induced thrombocytopenia and thrombosis syndrome: in vivo cross-reactivity with danaparoid and successful treatment with r-Hirudin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Generation of anti-hirudin antibodies in heparin-induced thrombocytopenic patients treated with r-hirudin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153857440203600302

10.1177/153857440203600302

21 January 2018

Identifiers

DOI

0 references

1 reference